Preferred Label : Glycopyrronium;
CAS number : A14FB57V1D;
Origin ID : M000682997;
Currated CISMeF NLP mapping
- Related record
https://www.has-sante.fr/jcms/p_3481441/fr/ultibro-breezhaler-indacaterol/bromure-de-glycopyrronium-bronchopneumopathie-chronique-obstructive-bpco
2024
false
false
false
France
indacaterol
insurance, health, reimbursement
treatment outcome
drug combinations
indacaterol-glycopyrronium combination
adult
administration, inhalation
evaluation of the transparency committee
Glycopyrronium
pulmonary disease, chronic obstructive
---
https://www.has-sante.fr/jcms/p_3499775/fr/sialanar-bromure-de-glycopyrronium-sialorrhee-severe
2024
false
false
false
France
insurance, health, reimbursement
treatment outcome
Glycopyrronium
glycopyrrolate
sialorrhea
glycopyrronium
nervous system diseases
chronic disease
child
adolescent
administration, oral
pharmaceutical solutions
evaluation of the transparency committee
---
https://ansm.sante.fr/tableau-marr/glycopyrronium
2023
false
false
false
France
French
guidelines for drug use
risk management
administration, oral
Glycopyrronium
glycopyrronium
patient education handout
muscarinic antagonists
muscarinic antagonists
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
Glycopyrronium
sialorrhea
child
adolescent
chronic disease
nervous system diseases
---
https://www.has-sante.fr/jcms/p_3281234/fr/trimbow-formoterol/-bromure-de-glycopyrronium/-beclometasone-asthme
2021
false
false
false
France
insurance, health, reimbursement
treatment outcome
drug combinations
administration, inhalation
beclomethasone
Beclomethasone Dipropionate
Formoterol Fumarate
Glycopyrronium
asthma
adult
adrenergic beta-2 receptor agonists
muscarinic antagonists
bronchodilator agents
glucocorticoids
formoterol, glycopyrronium bromide and beclometasone
evaluation of the transparency committee
---
